— Know what they know.
Not Investment Advice

OPTN NASDAQ

OptiNose, Inc.
1W: +1.9% 1M: +4.7% 3M: +60.0% 1Y: -49.2% 3Y: -65.4% 5Y: -83.6%
$9.60
Last traded 2025-05-21 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $97.2M mcap · 6M float · 1.87% daily turnover · Short 18% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$78M +10.2% ▲
5Y CAGR: +17.7%
Gross Profit
$71M +13.9% ▲
5Y CAGR: +19.3%
Operating Income
-$16M +28.3% ▲
Net Income
-$22M +39.3% ▲
EPS (Diluted)
$-2.12 -562.5% ▼
EBITDA
-$1M +92.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$49M$75M$76M$71M$78M
YoY Growth+41.8%+52.0%+2.2%-6.9%+10.2%
Cost of Revenue$8M$9M$9M$9M$7M
Gross Profit$42M$66M$67M$62M$71M
Gross Margin84.7%87.7%87.9%87.8%90.8%
R&D Expenses$23M$25M$15M$5M$4M
SG&A Expenses$105M$107M$108M$80M$83M
Operating Expenses$129M$132M$123M$85M$87M
Operating Income-$87M-$66M-$56M-$23M-$16M
Operating Margin-177.6%-89.0%-73.3%-32.0%-20.9%
Interest Expense$13M$16M$17M$20M$20M
Income Before Tax-$100M-$82M-$75M-$35M-$22M
Tax Expense-$1M$0$0$0$0
Net Income-$98M-$82M-$75M-$35M-$22M
Net Margin-200.2%-109.4%-98.1%-50.0%-27.5%
EPS (Diluted)$-2.04$-1.44$-13.05$-0.32$-2.12
EBITDA-$85M-$66M-$57M-$16M-$1M
Shares Outstanding48M57M6M112M10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms